VANESSA FLANNERY: Open Payments
NPI 1396238218 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,036 in 40 payments from 9 companies in 2025. Trend: 2023 $264 · 2024 $549 · 2025 $1,036
Food & beverage: $1,036
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $250 |
| Indivior Inc. | 7 | $204 |
| Janssen Pharmaceuticals, Inc | 2 | $180 |
| Otsuka America Pharmaceutical, Inc. | 5 | $175 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $104 |
| Braeburn Inc. | 4 | $68 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $21 |
| Lundbeck LLC | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: SUBLOCADE, REXULTI, SPRAVATO, VRAYLAR, CAPLYTA, MAVYRET, BRIXADI, JOURNAVX.
Industry payments across KY — which companies pay providers there.
